| Literature DB >> 17485528 |
James R Hair1,2, Paul A Lyons3,2, Kenneth G C Smith2, Stacey Efstathiou1.
Abstract
The replication and transcriptional activator (Rta), encoded by ORF50 of gammaherpesviruses, initiates the lytic cycle of gene expression; therefore understanding the impact of Rta on viral and cellular gene expression is key to elucidating the transcriptional events governing productive infection and reactivation from latency. To this end, the impact of altering Rta transcription on viral and cellular gene expression was studied in the context of a whole virus infection. Recombinant murine gammaherpesvirus (MHV)-68 engineered to overexpress Rta greatly accelerated expression of specific lytic cycle ORFs, but repressed transcription of the major latency gene, ORF73. Increased expression of Rta accelerated the dysregulation in transcription of specific cellular genes when compared with cells infected with wild-type and revertant viruses. A subset of cellular genes was dysregulated only in cells infected with Rta-overexpressing virus, and never in those infected with non-overexpressing viruses. These data highlight the critical role of Rta abundance in governing viral and cellular gene transcription, and demonstrate the importance of understanding how the relative expression of ORF50 during the virus life cycle impacts on these processes.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17485528 PMCID: PMC2884955 DOI: 10.1099/vir.0.82548-0
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891
Cellular genes dysregulated after MHV68 infection
Table shows fold changes for cellular genes that were dysregulated (criteria outlined in Methods) in infected cells. (a) Genes specifically dysregulated in M50-MHV68-infected cells at 2 h p.i. and (where applicable) also during a WT infection time course. No genes were identified as dysregulated in M50-infected cells at 1 h p.i. (b) Genes dysregulated only during a WT-MHV68 infection time course. For clarity, dysregulation of early growth response 1 at 1 h p.i. (−1.74) and the EST AW610815 at 1 and 2 h p.i. (1.79 and 1.74, respectively) are not shown. In all cases, positive and negative fold-changes indicate upregulation and downregulation of gene expression, respectively.
| (a) | |||||||
| Carboxypeptidase A3, mast cell | NM_007753 | 35.25 | |||||
| Tumour necrosis factor-induced protein 6 | U83903 | 3.66 | |||||
| Fibroblast growth factor 10 | U94517 | 2.14 | |||||
| Vascular cell adhesion molecule 1† | M84487 | 1.65 | |||||
| Transforming growth factor | NM_009366 | −1.66 | |||||
| EST expressed in B cells | AW495873 | −1.69 | |||||
| Myeloid differentiation primary response gene 118 | X54149 | −1.70 | |||||
| Platelet-derived growth factor receptor | M84607 | −1.71 | −1.67 | −2.09 | |||
| Nuclear factor I/A | D90173 | −1.71 | |||||
| CDC-like kinase 3 | AF033565 | −1.71 | |||||
| Integrin alpha V (CD51) | U14135 | −1.74 | |||||
| I | U57524 | −1.74 | −1.65 | ||||
| Vascular endothelial growth factor | U41383 | −1.75 | |||||
| Dual specificity phosphatase 1 | NM_013642 | −1.83 | −2.02 | ||||
| Enolase 2, | X52380 | −1.83 | |||||
| Supressor of cytokine signalling 5 | NM_019654 | −1.88 | |||||
| CCAAT/enhancer binding protein (C/EBP) | AY056052 | −1.88 | |||||
| Kruppel-like factor 4 (gut) | U70662 | −1.90 | |||||
| CCCTC-binding factor | U51037 | −1.91 | |||||
| Nur77 | NM_010444 | −2.00 | −2.20 | −1.93 | −1.74 | ||
| (b) | |||||||
| Urokinase plasminogen activator receptor | X62701 | 2.54 | 1.74 | ||||
| Small inducible cytokine A2 | M19681 | 2.36 | |||||
| AW610703 (EST) | AW610703 | 2.18 | |||||
| CD44 | M27130 | 1.97 | |||||
| Ephrin receptor A2 | U07634 | 1.93 | |||||
| Myc | NM_010849 | 1.72 | |||||
| Peroxisome proliferator activator receptor | L28116 | 1.67 | |||||
| Jun oncogene | J04115 | −1.65 | |||||
| Baculoviral IAP repeat-containing 2 | U88909 | −1.66 | |||||
| Viral envelope-like protein (G7e) gene | U69488 | −1.66 | |||||
| Homeo box A3 | Y11717 | −1.65 | −1.69 | −1.73 | |||
| Zinc finger protein 36, C3H type-like 1 | M58566 | −1.92 | −2.00 | ||||
| Zinc finger protein 36 | L42317 | −2.27 | −1.99 | −2.48 | |||
| Fos | NM_010234 | −2.44 | −2.25 | −2.57 | |||
| CD24a | X72910 | −1.67 | −2.14 | ||||
| Kruppel-like factor 2 (lung) | NM_008452 | −1.68 | −2.17 | ||||
| Jun proto-oncogene related gene d1 | J04509 | −1.76 | |||||
| Ly6 antigen | X04653 | −1.88 | −2.64 | ||||
| Fosb | NM_008036 | −2.04 | |||||
| Early growth response 1 | NM_007913 | −2.07 | |||||
| AW824577 (EST) | AW824577 | 3.52 | |||||
| AW825364 (EST) | AW825364 | −1.71 | |||||
| Inhibitor of DNA binding 3 | NM_008321 | −1.91 | |||||
| Deoxyribonuclease II | AF045741 | −1.92 | |||||
| Integrin beta 5 | AF043256 | −1.99 | |||||
| Platelet-derived growth factor receptor, | X04367 | −2.10 | |||||
| Lymphocyte antigen 6 complex, locus C | D86232 | −2.63 | |||||
| Lymphocyte antigen 6 complex | M37707 | −2.79 | |||||
*Non-dysregulated genes that did not meet the following criteria; >1.65×, t-test P value <0.05 and fluorescence in either infected or mock-infected Cy-dye channel >1000 units.
†P>0.05.
Fig. 1.Viral gene expression 1 h after infection with WT-, 50R- and M50-MHV68. 3T3 cells were infected at an m.o.i. of 5. RNA was extracted and analysed by DNA microarray. Fluorescence intensity (relative expression) of high-expression (fluorescence >1000) MHV68 ORFs (a) and low-expression (fluorescence <1000) MHV68 ORFs (b) in infected cells. Bars show mean fluorescence intensities (n=3), ± sd. ORF colours: yellow, Rta; red, DNA replication/transactivation; blue, virion structural/transport/assembly protein; green, latency-associated; black, unknown/other function. (c) Histogram showing fold-change differences in ORF expression when M50-infected cells are compared to WT- (grey) or 50R- (white) infected cells. Statistically significant fold changes (when M50 was compared with WT; P<0.05 by Student's t-test) are indicated by asterisks. The pie chart shows percentage of ORFs that (relative to WT-MHV68-infected cells) were upregulated >2-fold (↑), unchanged (↔) or downregulated >2-fold (↓).
Fig. 2.Q-RT-PCR confirmation of microarray data. 3T3 cells were infected (at an m.o.i. of 5) for 2 h with WT-, 50R- or M50-MHV68 and expression of CPA3, TNFIP6, FGF10, VCAM-1 and VEGF was determined using Q-RT-PCR. Bars show mean fold changes (n=3 infections) normalized to loading controls (β-2 microglobulin or glyceraldehyde-3-phosphate dehydrogenase) in cells infected with 50R- (white) and M50- (black) relative to WT-MHV68 (grey). P values according to Student's t-test are shown (*, P<0.05; **, P<0.01; ***, P<0.001). There was no statistically significant difference between WT- and 50R-MHV68 values for any of the genes tested.
Fig. 3.Expression of VCAM-1 protein in infected cells. 3T3 cells were infected with WT-, 50R- or M50-MHV68 for 2, 4, 6 and 10 h. (a) Cell lysates were subjected to gel electrophoresis, the proteins were transferred to a nitrocellulose membrane and VCAM-1 was detected using biotinylated anti-VCAM-1 with anti-IgG streptavidin–horseradish peroxidase antibodies. +, Uninfected 3T3 cells; −, uninfected 3T3 cells with irrelevant (anti-mouse IgM biotin) primary antibody. (b) Densitometry of the protein bands was performed and VCAM-1 values were normalized to β-actin controls. For each time point, VCAM-1 expression in 50R- (white) and M50- (black) infected cells is shown relative to that in WT-MHV68 (grey) -infected cells (set to 1). (c) FACS analysis of cell-surface VCAM-1 was performed using 3T3 cells infected for 10 h with WT- (blue), 50R- (green) or M50-MHV68 (red) and is shown relative to WT-MHV68-infected cells stained with isotype control antibody (black).